{"filter":{"intervention":"vaccine"},"n_projects":18,"projects":[{"accession":"PRJEB85985","age_categories":{"adult":768},"countries":{"DE":768},"first_public_year":"2025","gbp_per_sample_median":8.37,"has_cases_and_healthy_controls":false,"has_treated_and_control_arms":false,"health_conditions":{"healthy_control":768},"intervention_design":"single_arm_before_after","intervention_detail":"SARS-CoV-2 vaccination, pre/post sampling","interventions":["vaccine"],"n_samples":768,"papers":[{"doi":"10.1101/2025.02.21.639485","pmcid":null,"pmid":null,"title":"Flagellin in the human gut microbiome is a diet-adjustable adjuvant for vaccination"}],"sample_intervention_arms":{},"sex":{},"title":"Microbial-Human Ecology and Temperature","trial_population_condition":"healthy_control","urls":{"ena":"https://www.ebi.ac.uk/ena/browser/view/PRJEB85985","evidence_csv_gz":"https://olmlab.github.io/microbiome_repo/data/studies/PRJEB85985_determinations.csv.gz","page":"https://olmlab.github.io/microbiome_repo/studies/PRJEB85985.html","samples_csv":"https://olmlab.github.io/microbiome_repo/api/samples/PRJEB85985.csv","samples_full_csv_gz":"https://olmlab.github.io/microbiome_repo/data/studies/PRJEB85985.csv.gz"}},{"accession":"PRJNA807448","age_categories":{"infant":193,"neonate":266},"countries":{"AU":459},"first_public_year":"2025","gbp_per_sample_median":4.85,"has_cases_and_healthy_controls":false,"has_treated_and_control_arms":false,"health_conditions":{"healthy_control":459},"intervention_design":"observational_with_procedure","intervention_detail":"Routine infant vaccination (PCV13, 6-in-1 Infanrix Hexa); observed antibiotic exposure","interventions":["vaccine"],"n_samples":459,"papers":[{"doi":"10.1038/s41586-025-08796-4","pmcid":"PMC12058517","pmid":"40175554","title":"Bifidobacteria support optimal infant vaccine responses."}],"sample_intervention_arms":{},"sex":{"female":146,"male":191},"title":"The Antibiotics and Immune Responses Study","trial_population_condition":"healthy_control","urls":{"ena":"https://www.ebi.ac.uk/ena/browser/view/PRJNA807448","evidence_csv_gz":"https://olmlab.github.io/microbiome_repo/data/studies/PRJNA807448_determinations.csv.gz","page":"https://olmlab.github.io/microbiome_repo/studies/PRJNA807448.html","samples_csv":"https://olmlab.github.io/microbiome_repo/api/samples/PRJNA807448.csv","samples_full_csv_gz":"https://olmlab.github.io/microbiome_repo/data/studies/PRJNA807448.csv.gz"}},{"accession":"PRJNA685797","age_categories":{"adult":318,"elderly":5},"countries":{"NL":323},"first_public_year":"2021","gbp_per_sample_median":4.03,"has_cases_and_healthy_controls":false,"has_treated_and_control_arms":false,"health_conditions":{"healthy_control":323},"intervention_design":"single_arm_before_after","intervention_detail":"BCG vaccination with pre/post blood and stool sampling","interventions":["vaccine"],"n_samples":323,"papers":[{"doi":"10.1186/s13059-021-02482-0","pmcid":"PMC8456614","pmid":"34551799","title":"The influence of the gut microbiome on BCG-induced trained immunity."},{"doi":"10.1016/j.ebiom.2026.106404","pmcid":"PMC13427514","pmid":"42492179","title":"Investigating the role of baseline gut Akkermansia muciniphila and its co-metabolite palmitoleic acid in BCG vaccine efficacy: a preclinical study."}],"sample_intervention_arms":{},"sex":{"female":181,"male":139},"title":"The Influence of the gut microbiome on BCG-induced trained immunity","trial_population_condition":"healthy_control","urls":{"ena":"https://www.ebi.ac.uk/ena/browser/view/PRJNA685797","evidence_csv_gz":"https://olmlab.github.io/microbiome_repo/data/studies/PRJNA685797_determinations.csv.gz","page":"https://olmlab.github.io/microbiome_repo/studies/PRJNA685797.html","samples_csv":"https://olmlab.github.io/microbiome_repo/api/samples/PRJNA685797.csv","samples_full_csv_gz":"https://olmlab.github.io/microbiome_repo/data/studies/PRJNA685797.csv.gz"}},{"accession":"PRJEB48269","age_categories":{"unknown":272},"countries":{"HK":272},"first_public_year":"2022","gbp_per_sample_median":7.74,"has_cases_and_healthy_controls":false,"has_treated_and_control_arms":false,"health_conditions":{"healthy_control":272},"intervention_design":"observational_with_procedure","intervention_detail":"BNT162b2 mRNA or CoronaVac inactivated SARS-CoV-2 vaccine, 2 doses","interventions":["vaccine"],"n_samples":272,"papers":[{"doi":"10.1136/gutjnl-2021-326563","pmcid":"PMC8844967","pmid":"35140064","title":"Gut microbiota composition is associated with SARS-CoV-2 vaccine immunogenicity and adverse events."},{"doi":"10.1038/s42003-023-04755-9","pmcid":"PMC10119155","pmid":"37081096","title":"Human immune and gut microbial parameters associated with inter-individual variations in COVID-19 mRNA vaccine-induced immunity."},{"doi":"10.1038/s41392-023-01629-8","pmcid":"PMC10518331","pmid":"37743379","title":"Baseline gut microbiota and metabolome predict durable immunogenicity to SARS-CoV-2 vaccines."}],"sample_intervention_arms":{"vaccine":272},"sex":{},"title":"Gut microbiota composition modulates SARS-CoV-2 vaccine immunogenicity and vaccine-related adverse effects","trial_population_condition":"healthy_control","urls":{"ena":"https://www.ebi.ac.uk/ena/browser/view/PRJEB48269","evidence_csv_gz":"https://olmlab.github.io/microbiome_repo/data/studies/PRJEB48269_determinations.csv.gz","page":"https://olmlab.github.io/microbiome_repo/studies/PRJEB48269.html","samples_csv":"https://olmlab.github.io/microbiome_repo/api/samples/PRJEB48269.csv","samples_full_csv_gz":"https://olmlab.github.io/microbiome_repo/data/studies/PRJEB48269.csv.gz"}},{"accession":"PRJEB60773","age_categories":{"adult":248},"countries":{"HK":248},"first_public_year":"2023","gbp_per_sample_median":4.2,"has_cases_and_healthy_controls":false,"has_treated_and_control_arms":false,"health_conditions":{"healthy_control":248},"intervention_design":"observational_with_procedure","intervention_detail":"BNT162b2 or CoronaVac COVID-19 vaccination, followed longitudinally","interventions":["vaccine"],"n_samples":248,"papers":[{"doi":"10.1038/s41392-023-01629-8","pmcid":"PMC10518331","pmid":"37743379","title":"Baseline gut microbiota and metabolome predict durable immunogenicity to SARS-CoV-2 vaccines."}],"sample_intervention_arms":{"vaccine":199},"sex":{},"title":"Long-term interplays between COVID-19 vaccines and the gut microbiome","trial_population_condition":"healthy_control","urls":{"ena":"https://www.ebi.ac.uk/ena/browser/view/PRJEB60773","evidence_csv_gz":"https://olmlab.github.io/microbiome_repo/data/studies/PRJEB60773_determinations.csv.gz","page":"https://olmlab.github.io/microbiome_repo/studies/PRJEB60773.html","samples_csv":"https://olmlab.github.io/microbiome_repo/api/samples/PRJEB60773.csv","samples_full_csv_gz":"https://olmlab.github.io/microbiome_repo/data/studies/PRJEB60773.csv.gz"}},{"accession":"PRJNA983517","age_categories":{"adult":242},"countries":{"HK":242},"first_public_year":"2023","gbp_per_sample_median":10.09,"has_cases_and_healthy_controls":false,"has_treated_and_control_arms":false,"health_conditions":{"healthy_control":242},"intervention_design":"observational_with_procedure","intervention_detail":"BNT162b2 mRNA COVID-19 vaccine, two-dose recipients observed","interventions":["vaccine"],"n_samples":242,"papers":[{"doi":"10.3389/fimmu.2025.1534787","pmcid":"PMC11903479","pmid":"40083550","title":"Gut microbiota is associated with persistence of longer-term BNT162b2 vaccine immunogenicity."}],"sample_intervention_arms":{},"sex":{},"title":"Gut microbiota is associated with longer-term vaccine immunogenicity of BNT162b2","trial_population_condition":"healthy_control","urls":{"ena":"https://www.ebi.ac.uk/ena/browser/view/PRJNA983517","evidence_csv_gz":"https://olmlab.github.io/microbiome_repo/data/studies/PRJNA983517_determinations.csv.gz","page":"https://olmlab.github.io/microbiome_repo/studies/PRJNA983517.html","samples_csv":"https://olmlab.github.io/microbiome_repo/api/samples/PRJNA983517.csv","samples_full_csv_gz":"https://olmlab.github.io/microbiome_repo/data/studies/PRJNA983517.csv.gz"}},{"accession":"PRJEB66197","age_categories":{"adult":173},"countries":{"NL":173},"first_public_year":"2023","gbp_per_sample_median":5.62,"has_cases_and_healthy_controls":false,"has_treated_and_control_arms":false,"health_conditions":{"other_cancer":173},"intervention_design":"randomized_controlled_trial","intervention_detail":"Autologous natural dendritic cell injections vs placebo, adjuvant","interventions":["vaccine"],"n_samples":173,"papers":[{"doi":"10.1038/s41467-024-45357-1","pmcid":"PMC10891084","pmid":"38395948","title":"Influence of microbiota-associated metabolic reprogramming on clinical outcome in patients with melanoma from the randomized adjuvant dendritic cell-based MIND-DC trial."},{"doi":"10.21203/rs.3.rs-4294379/v1","pmcid":null,"pmid":null,"title":"Gut microbiota: a new factor modulating the immunizing potential of viral and cancer vaccines"}],"sample_intervention_arms":{},"sex":{},"title":"Microbiota-associated metabolic reprograming influenced clinical outcome in the randomized dendritic cell-based clinical trial in stage III melanoma","trial_population_condition":"other_cancer","urls":{"ena":"https://www.ebi.ac.uk/ena/browser/view/PRJEB66197","evidence_csv_gz":"https://olmlab.github.io/microbiome_repo/data/studies/PRJEB66197_determinations.csv.gz","page":"https://olmlab.github.io/microbiome_repo/studies/PRJEB66197.html","samples_csv":"https://olmlab.github.io/microbiome_repo/api/samples/PRJEB66197.csv","samples_full_csv_gz":"https://olmlab.github.io/microbiome_repo/data/studies/PRJEB66197.csv.gz"}},{"accession":"PRJNA644725","age_categories":{"unknown":150},"countries":{"BD":113,"US":34},"first_public_year":"2020","gbp_per_sample_median":2.13,"has_cases_and_healthy_controls":false,"has_treated_and_control_arms":false,"health_conditions":{},"intervention_design":"observational_with_procedure","intervention_detail":"Oral poliovirus vaccine (OPV) administered to infants","interventions":["vaccine"],"n_samples":150,"papers":[{"doi":"10.1038/s41598-020-71791-4","pmcid":"PMC7506025","pmid":"32958861","title":"Metagenomic sequencing of stool samples in Bangladeshi infants: virome association with poliovirus shedding after oral poliovirus vaccination."},{"doi":"10.1128/spectrum.00665-23","pmcid":"PMC10269646","pmid":"37191543","title":"Exploring Molecular Interactions between Human Milk Hormone Insulin and Bifidobacteria."},{"doi":"10.1128/msystems.01294-23","pmcid":"PMC11019788","pmid":"38441032","title":"Taxonomic and metabolic development of the human gut microbiome across life stages: a worldwide metagenomic investigation."},{"doi":"10.1038/s41522-025-00868-7","pmcid":"PMC12769767","pmid":"41350579","title":"Compiling an early life human gut microbiome atlas and identification of key microbial drivers."}],"sample_intervention_arms":{},"sex":{},"title":"Metagenomic Sequencing of Stool Samples in Bangladeshi Infants: Virome Association with Poliovirus Shedding After Oral Poliovirus Vaccination","trial_population_condition":"healthy_control","urls":{"ena":"https://www.ebi.ac.uk/ena/browser/view/PRJNA644725","evidence_csv_gz":"https://olmlab.github.io/microbiome_repo/data/studies/PRJNA644725_determinations.csv.gz","page":"https://olmlab.github.io/microbiome_repo/studies/PRJNA644725.html","samples_csv":"https://olmlab.github.io/microbiome_repo/api/samples/PRJNA644725.csv","samples_full_csv_gz":"https://olmlab.github.io/microbiome_repo/data/studies/PRJNA644725.csv.gz"}},{"accession":"PRJNA983760","age_categories":{"adult":119},"countries":{"HK":119},"first_public_year":"2023","gbp_per_sample_median":9.88,"has_cases_and_healthy_controls":false,"has_treated_and_control_arms":false,"health_conditions":{},"intervention_design":"single_arm_before_after","intervention_detail":"Two-dose CoronaVac COVID-19 vaccine, baseline stool, day180 antibody","interventions":["vaccine"],"n_samples":119,"papers":[{"doi":"10.3390/ijms25052583","pmcid":"PMC10931755","pmid":"38473829","title":"The Predictive Value of Gut Microbiota Composition for Sustained Immunogenicity following Two Doses of CoronaVac."}],"sample_intervention_arms":{},"sex":{},"title":"Gut microbiota is associated with longer-term vaccine immunogenicity of CoronaVac","trial_population_condition":"healthy_control","urls":{"ena":"https://www.ebi.ac.uk/ena/browser/view/PRJNA983760","evidence_csv_gz":"https://olmlab.github.io/microbiome_repo/data/studies/PRJNA983760_determinations.csv.gz","page":"https://olmlab.github.io/microbiome_repo/studies/PRJNA983760.html","samples_csv":"https://olmlab.github.io/microbiome_repo/api/samples/PRJNA983760.csv","samples_full_csv_gz":"https://olmlab.github.io/microbiome_repo/data/studies/PRJNA983760.csv.gz"}},{"accession":"PRJNA1300320","age_categories":{"adult":89,"elderly":25},"countries":{"SE":114},"first_public_year":"2026","gbp_per_sample_median":9.16,"has_cases_and_healthy_controls":true,"has_treated_and_control_arms":false,"health_conditions":{"healthy_control":75,"other_infection":39},"intervention_design":"observational_with_procedure","intervention_detail":"SARS-CoV-2 vaccination in PLWH and healthy controls","interventions":["vaccine"],"n_samples":114,"papers":[],"sample_intervention_arms":{},"sex":{"female":58,"male":56},"title":"Association of metabolic pathways and antibiotic resistance gene dynamics with SARS-CoV-2 vaccine efficacy in PLWH","trial_population_condition":"transplant_or_immunocompromised","urls":{"ena":"https://www.ebi.ac.uk/ena/browser/view/PRJNA1300320","evidence_csv_gz":"https://olmlab.github.io/microbiome_repo/data/studies/PRJNA1300320_determinations.csv.gz","page":"https://olmlab.github.io/microbiome_repo/studies/PRJNA1300320.html","samples_csv":"https://olmlab.github.io/microbiome_repo/api/samples/PRJNA1300320.csv","samples_full_csv_gz":"https://olmlab.github.io/microbiome_repo/data/studies/PRJNA1300320.csv.gz"}},{"accession":"PRJNA782606","age_categories":{"adolescent":9,"adult":45,"child":21,"infant":14},"countries":{"BD":89},"first_public_year":"2022","gbp_per_sample_median":3.96,"has_cases_and_healthy_controls":false,"has_treated_and_control_arms":false,"health_conditions":{"healthy_control":89},"intervention_design":"observational_with_procedure","intervention_detail":"Oral cholera vaccine administration, pre-vaccination fecal microbiota sampled","interventions":["vaccine"],"n_samples":89,"papers":[{"doi":"10.1038/s41467-025-67388-y","pmcid":"PMC12816596","pmid":"41388019","title":"Gut bacteria-derived sphingolipids alter innate immune responses to oral cholera vaccine antigens."}],"sample_intervention_arms":{},"sex":{"female":55,"male":34},"title":"Gut microbiota at time of cholera vaccination","trial_population_condition":"healthy_control","urls":{"ena":"https://www.ebi.ac.uk/ena/browser/view/PRJNA782606","evidence_csv_gz":"https://olmlab.github.io/microbiome_repo/data/studies/PRJNA782606_determinations.csv.gz","page":"https://olmlab.github.io/microbiome_repo/studies/PRJNA782606.html","samples_csv":"https://olmlab.github.io/microbiome_repo/api/samples/PRJNA782606.csv","samples_full_csv_gz":"https://olmlab.github.io/microbiome_repo/data/studies/PRJNA782606.csv.gz"}},{"accession":"PRJEB32834","age_categories":{"unknown":74},"countries":{},"first_public_year":"2020","gbp_per_sample_median":6.0,"has_cases_and_healthy_controls":false,"has_treated_and_control_arms":false,"health_conditions":{},"intervention_design":"single_arm_before_after","intervention_detail":"DTP and influenza vaccination, sampled pre- and 6-weeks post-vaccination","interventions":["vaccine"],"n_samples":74,"papers":[],"sample_intervention_arms":{},"sex":{},"title":"Microbiome_based_prediction_of_vaccine_response_in_elderly_patients","trial_population_condition":"healthy_control","urls":{"ena":"https://www.ebi.ac.uk/ena/browser/view/PRJEB32834","evidence_csv_gz":"https://olmlab.github.io/microbiome_repo/data/studies/PRJEB32834_determinations.csv.gz","page":"https://olmlab.github.io/microbiome_repo/studies/PRJEB32834.html","samples_csv":"https://olmlab.github.io/microbiome_repo/api/samples/PRJEB32834.csv","samples_full_csv_gz":"https://olmlab.github.io/microbiome_repo/data/studies/PRJEB32834.csv.gz"}},{"accession":"PRJEB42384","age_categories":{"unknown":73},"countries":{"ES":73},"first_public_year":"2022","gbp_per_sample_median":2.96,"has_cases_and_healthy_controls":false,"has_treated_and_control_arms":false,"health_conditions":{"other_infection":73},"intervention_design":"single_arm_before_after","intervention_detail":"MVA.HIVconsv therapeutic vaccine plus romidepsin latency-reversing agent","interventions":["drug_therapy","vaccine"],"n_samples":73,"papers":[{"doi":"10.1186/s40168-022-01247-6","pmcid":"PMC9004083","pmid":"35410461","title":"Gut microbiome signatures linked to HIV-1 reservoir size and viremia control."}],"sample_intervention_arms":{},"sex":{},"title":"BCN02_ROMI_Microbiome","trial_population_condition":"unknown","urls":{"ena":"https://www.ebi.ac.uk/ena/browser/view/PRJEB42384","evidence_csv_gz":"https://olmlab.github.io/microbiome_repo/data/studies/PRJEB42384_determinations.csv.gz","page":"https://olmlab.github.io/microbiome_repo/studies/PRJEB42384.html","samples_csv":"https://olmlab.github.io/microbiome_repo/api/samples/PRJEB42384.csv","samples_full_csv_gz":"https://olmlab.github.io/microbiome_repo/data/studies/PRJEB42384.csv.gz"}},{"accession":"PRJNA886719","age_categories":{"unknown":37},"countries":{"CH":1,"US":36},"first_public_year":"2022","gbp_per_sample_median":3.73,"has_cases_and_healthy_controls":false,"has_treated_and_control_arms":false,"health_conditions":{"healthy_control":37},"intervention_design":"randomized_controlled_trial","intervention_detail":"HIV-1 candidate vaccine (gp41/gp120 immunogens) vs placebo, HVTN trials","interventions":["vaccine"],"n_samples":37,"papers":[{"doi":"10.3389/fimmu.2022.983313","pmcid":"PMC9597301","pmid":"36311720","title":"Multi-trial analysis of HIV-1 envelope gp41-reactive antibodies among global recipients of candidate HIV-1 vaccines."}],"sample_intervention_arms":{},"sex":{},"title":"Multi-trial analysis of HIV-1 envelope gp41-reactive antibodies among global recipients of candidate HIV-1 vaccines.","trial_population_condition":"healthy_control","urls":{"ena":"https://www.ebi.ac.uk/ena/browser/view/PRJNA886719","evidence_csv_gz":"https://olmlab.github.io/microbiome_repo/data/studies/PRJNA886719_determinations.csv.gz","page":"https://olmlab.github.io/microbiome_repo/studies/PRJNA886719.html","samples_csv":"https://olmlab.github.io/microbiome_repo/api/samples/PRJNA886719.csv","samples_full_csv_gz":"https://olmlab.github.io/microbiome_repo/data/studies/PRJNA886719.csv.gz"}},{"accession":"PRJEB6972","age_categories":{"unknown":15},"countries":{"ES":15},"first_public_year":"2014","gbp_per_sample_median":5.03,"has_cases_and_healthy_controls":false,"has_treated_and_control_arms":false,"health_conditions":{},"intervention_design":"single_arm_before_after","intervention_detail":"Oral rotavirus vaccine, samples before/after each dose","interventions":["vaccine"],"n_samples":15,"papers":[{"doi":"10.1038/srep07417","pmcid":"PMC4261165","pmid":"25491920","title":"The establishment of the infant intestinal microbiome is not affected by rotavirus vaccination."}],"sample_intervention_arms":{},"sex":{},"title":"The microbial colonization of the intestine during the first monthsof life constitutes the most important process for the microbiota-induced host-homeostasis.Alterations in this process may entail a high-risk for disease in later life. However, this process the potential factorsaffecting it in the infant are not well known. Moreover, the potential impact of orally administered vaccines, expected to interact with intestinal immune cells eliciting an immune response at mucosal level,upon the establishing microbiome remains unknown.Here we assessed the intestinal microbiome establishmentprocess and evaluated the impact of rotavirus vaccination upon this process. Metagenomic, PCR-DGGE and faecal short chain fatty acids analyses were performed on faecal samples obtained from three infants before and after the administration of each dose of vaccine. We found a high inter-individual variability in the early lifegut microbiota at microbial composition level, but a large similarity between the infants’ microbiomes at functional level. Rotavirus vaccination did not show any major effects upon the infant gut microbiota. Thus, the individual microbiome establishment and development process seems to occur in a defined manner during the first stages of life and it is not affected by oral rotavirus vaccination.","trial_population_condition":"healthy_control","urls":{"ena":"https://www.ebi.ac.uk/ena/browser/view/PRJEB6972","evidence_csv_gz":"https://olmlab.github.io/microbiome_repo/data/studies/PRJEB6972_determinations.csv.gz","page":"https://olmlab.github.io/microbiome_repo/studies/PRJEB6972.html","samples_csv":"https://olmlab.github.io/microbiome_repo/api/samples/PRJEB6972.csv","samples_full_csv_gz":"https://olmlab.github.io/microbiome_repo/data/studies/PRJEB6972.csv.gz"}},{"accession":"PRJNA1067375","age_categories":{"unknown":11},"countries":{"KR":11},"first_public_year":"2024","gbp_per_sample_median":6.79,"has_cases_and_healthy_controls":false,"has_treated_and_control_arms":false,"health_conditions":{"healthy_control":11},"intervention_design":"observational_with_procedure","intervention_detail":"SARS-CoV-2 vaccination (primary series and booster)","interventions":["vaccine"],"n_samples":11,"papers":[{"doi":"10.1186/s12967-024-05637-2","pmcid":"PMC11380214","pmid":"39242525","title":"The gut microbiota modifies antibody durability and booster responses after SARS-CoV-2 vaccination."}],"sample_intervention_arms":{},"sex":{},"title":"Gut microbiome after SARS-CoV-2 vaccination","trial_population_condition":"healthy_control","urls":{"ena":"https://www.ebi.ac.uk/ena/browser/view/PRJNA1067375","evidence_csv_gz":"https://olmlab.github.io/microbiome_repo/data/studies/PRJNA1067375_determinations.csv.gz","page":"https://olmlab.github.io/microbiome_repo/studies/PRJNA1067375.html","samples_csv":"https://olmlab.github.io/microbiome_repo/api/samples/PRJNA1067375.csv","samples_full_csv_gz":"https://olmlab.github.io/microbiome_repo/data/studies/PRJNA1067375.csv.gz"}},{"accession":"PRJNA493153","age_categories":{"adult":10},"countries":{},"first_public_year":"2018","gbp_per_sample_median":2.84,"has_cases_and_healthy_controls":false,"has_treated_and_control_arms":false,"health_conditions":{"other_cancer":10},"intervention_design":"unknown","intervention_detail":"Therapeutic HPV vaccine for HNSCC, sampled before injection","interventions":["vaccine"],"n_samples":10,"papers":[{"doi":"10.3389/fmicb.2018.03349","pmcid":"PMC6353838","pmid":"30733714","title":"SqueezeMeta, A Highly Portable, Fully Automatic Metagenomic Analysis Pipeline."},{"doi":"10.1186/s12859-020-03777-y","pmcid":"PMC7576720","pmid":"33081690","title":"CDKAM: a taxonomic classification tool using discriminative k-mers and approximate matching strategies."}],"sample_intervention_arms":{},"sex":{},"title":"Gut Microbiome Sequencing of Head and Neck Cancer Patients","trial_population_condition":"other_cancer","urls":{"ena":"https://www.ebi.ac.uk/ena/browser/view/PRJNA493153","evidence_csv_gz":"https://olmlab.github.io/microbiome_repo/data/studies/PRJNA493153_determinations.csv.gz","page":"https://olmlab.github.io/microbiome_repo/studies/PRJNA493153.html","samples_csv":"https://olmlab.github.io/microbiome_repo/api/samples/PRJNA493153.csv","samples_full_csv_gz":"https://olmlab.github.io/microbiome_repo/data/studies/PRJNA493153.csv.gz"}},{"accession":"PRJEB103086","age_categories":{"unknown":4},"countries":{"CH":4},"first_public_year":"2025","gbp_per_sample_median":3.17,"has_cases_and_healthy_controls":false,"has_treated_and_control_arms":false,"health_conditions":{},"intervention_design":"observational_with_procedure","intervention_detail":"mRNA vaccination; gut microbiota effect on humoral response","interventions":["vaccine"],"n_samples":4,"papers":[],"sample_intervention_arms":{},"sex":{},"title":"Gut microbiota shape humoral responses to mRNA vaccines through metabolic remodeling","trial_population_condition":"unknown","urls":{"ena":"https://www.ebi.ac.uk/ena/browser/view/PRJEB103086","evidence_csv_gz":"https://olmlab.github.io/microbiome_repo/data/studies/PRJEB103086_determinations.csv.gz","page":"https://olmlab.github.io/microbiome_repo/studies/PRJEB103086.html","samples_csv":"https://olmlab.github.io/microbiome_repo/api/samples/PRJEB103086.csv","samples_full_csv_gz":"https://olmlab.github.io/microbiome_repo/data/studies/PRJEB103086.csv.gz"}}],"release":"R2026.25"}